Literature DB >> 30309793

Predictors of preterm birth.

Yves Ville1, Patrick Rozenberg2.   

Abstract

Cervical length (CL) measured by transvaginal ultrasound examination (TVUE) best identifies the risk for preterm birth (PTB). It identifies women at risk who can benefit from corticosteroids or in utero transfer. Early screening improves effectiveness of tocolysis. It reduces iatrogenicity and cost. In preterm premature rupture of membranes (PPROM), CL is devoid of infectious risk and predicts duration of the latency phase but not the risk of perinatal sepsis. Asymptomatic women at risk should be screened at a 2-week interval starting from 16 to 18 weeks, up to 24 weeks. CLs <10th centile are at risk of PTB, especially with decrease in CL after 16 weeks. Repeat ultrasound improves predictive values. Stable CL calls for term delivery. Funneling does not improve predictivity of CL. In twin pregnancies, CL reduces unnecessary interventions. In symptomatic women, fetal fibronectin performs less than CL. Its combination with inconclusive CL has not emerged productive through randomized controlled trials (RCTs), and studies with homogeneous management for preterm labor (PTL) suggest that up to 15% of unjustified hospitalizations and treatment could be avoided.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cervical length; Fetal fibronectin; Prediction; Preterm delivery; Preterm labor; Transvaginal ultrasound

Mesh:

Substances:

Year:  2018        PMID: 30309793     DOI: 10.1016/j.bpobgyn.2018.05.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  8 in total

Review 1.  Alvarez waves in pregnancy: a comprehensive review.

Authors:  Sara Russo; Arnaldo Batista; Filipa Esgalhado; Catarina R Palma Dos Reis; Fátima Serrano; Valentina Vassilenko; Manuel Ortigueira
Journal:  Biophys Rev       Date:  2021-07-08

2.  Recurrent preterm birth risk assessment for two delivery subtypes: A multivariable analysis.

Authors:  Ilia Rattsev; Natalie Flaks-Manov; Angie C Jelin; Jiawei Bai; Casey Overby Taylor
Journal:  J Am Med Inform Assoc       Date:  2022-01-12       Impact factor: 7.942

3.  Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth.

Authors:  Heli Tiensuu; Antti M Haapalainen; Mikko Hallman; Mika Rämet; Pinja Tissarinen; Anu Pasanen; Tomi A Määttä; Johanna M Huusko; Steffen Ohlmeier; Ulrich Bergmann; Marja Ojaniemi; Louis J Muglia
Journal:  BMC Med       Date:  2022-04-28       Impact factor: 11.150

4.  Immunometabolic Analysis of Mobiluncus mulieris and Eggerthella sp. Reveals Novel Insights Into Their Pathogenic Contributions to the Hallmarks of Bacterial Vaginosis.

Authors:  Ross McKenzie; Jason D Maarsingh; Paweł Łaniewski; Melissa M Herbst-Kralovetz
Journal:  Front Cell Infect Microbiol       Date:  2021-12-23       Impact factor: 5.293

5.  Iatrogenic factors contributed to the high rate of preterm birth in a community hospital.

Authors:  Lu Huang; Zhong Chen; Jiawen Li; Yuanyuan Chen; Ke Yin; Yu Chen; Lingqing Hu; Xiaomin Zheng; Tao Zhou; Yunlong Zhu; Daozhen Chen; Nanbert Zhong
Journal:  Transl Pediatr       Date:  2021-10

6.  Construction and validation of a preterm birth risk assessment model using fuzzy analytic hierarchy process.

Authors:  Stavroula Barbounaki; Antigoni Sarantaki
Journal:  Bosn J Basic Med Sci       Date:  2022-04-01       Impact factor: 3.363

7.  Machine Learning-Based Prediction Model of Preterm Birth Using Electronic Health Record.

Authors:  Qi Sun; Xiaoxuan Zou; Yousheng Yan; Hongguang Zhang; Shuo Wang; Yongmei Gao; Haiyan Liu; Shuyu Liu; Jianbo Lu; Ying Yang; Xu Ma
Journal:  J Healthc Eng       Date:  2022-04-13       Impact factor: 3.822

8.  Effects of vaginal microbiota and cervical cerclage on obstetric outcomes of twin pregnancies with cervical incompetence: a retrospective study.

Authors:  Xuan Zhou; Xiao-Xue Li; Yi-Meng Ge; Shao-Yang Lai; Luo-Qi Zhou; Ling Feng; Jie Zhao
Journal:  Arch Gynecol Obstet       Date:  2021-08-05       Impact factor: 2.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.